Aquestive Therapeutics, Inc. - Common Stock — Statistiche Finanziarie (NASDAQ:AQST) | MetaTrader

Apri il grafico completo Full chart

Notizie

Citizens conferma il rating su Aquestive grazie ai progressi di Anaphylm

Relazione sugli utili Aquestive Q1 2026: risultati sopra le attese, titolo in rialzo

Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics

Aquestive Therapeutics (AQST) Reports Q1 Loss, Beats Revenue Estimates

Gli EPS di Aquestive Therapeutics hanno battuto le aspettative per 0,06$, il fatturato supera le previsioni

Aquestive ottiene una linea di credito da 150 milioni di dollari con Oaktree

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Beats Revenue Estimates

Will Journey Medical Corporation (DERM) Report Negative Q1 Earnings? What You Should Know

Will Aquestive Therapeutics (AQST) Report Negative Q1 Earnings? What You Should Know

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Aquestive riconferma la ripresentazione dell’NDA per Anaphylm nel Q3 2026

Aquestive nomina Thomas Zalewski come chief legal officer